Proposed Collection; Comment Request; Educational Needs Assessment of International Drug Abuse Researchers, 10539-10540 [E6-2824]

Download as PDF Federal Register / Vol. 71, No. 40 / Wednesday, March 1, 2006 / Notices The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: February 23, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–2836 Filed 2–28–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket Number NIOSH–063] National Institute for Occupational Safety and Health Meeting wwhite on PROD1PC61 with NOTICES The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) announces the following public meeting: Name: Stakeholders’ Meeting to Seek Input on the NIOSH Fire Fighter Fatality Investigation and Prevention Program (FFFIPP) Meeting Date and Time: March 22, 2006, 9 a.m.–5 p.m. Place: Washington Court Hotel, Atrium Ballroom, 525 New Jersey Avenue NW., Washington, DC 20001. Status: This meeting is hosted by NIOSH and will be open to the public, limited only by the space available. The meeting room will accommodate approximately 120 people. Interested parties should make hotel reservations directly with the Washington Court Hotel (202–628–2100 or 800–321– 3010) and reference the NIOSH Fire Fighter Meeting. Interested parties should confirm their attendance to this meeting by completing a registration form and forwarding it by e-mail to the NIOSH Event Management Office, npptlevents@cdc.gov or fax (304–225–2003). A registration form may be obtained from the NIOSH Web site: https:// www.cdc.gov/niosh/fire/pdfs/registration.pdf. Purpose: The public meeting will seek stakeholder input on the progress and future directions of the NIOSH FFFIPP to ensure that the program is meeting the needs of the stakeholders, and to identify ways in which the program can be improved to increase its impact on the safety and health of fire fighters across the United States. NIOSH will compile and consider all comments received at the meeting and through the NIOSH docket and use them in making decisions on how to proceed with FFFIPP. Background: NIOSH convened a similar stakeholders’ meeting in January 1998 to seek input to help guide the planning for the VerDate Aug<31>2005 18:25 Feb 28, 2006 Jkt 208001 FFFIPP. The input provided by stakeholders at that meeting was very valuable in providing insight into stakeholder needs and in helping to establish the FFFIPP. The March 2006 meeting will be held to again seek stakeholder input. A document, ‘‘National Institute for Occupational Safety and Health (NIOSH) Fire Fighter Fatality Investigation and Prevention Program, 1998–2005’’ may be obtained from the NIOSH Web site https://www.cdc.gov/ niosh/fire/progress.html or https:// www.cdc.gov/niosh/fire/pdfs/progress.pdf. This document summarizes FFFIPP progress, possible future directions, and specific areas of NIOSH interest for stakeholder input. Copies of the document will also be available at the March 22, 2006 stakeholders’ meeting. Format of Meeting: The NIOSH Director, Dr. John Howard, will provide opening remarks, followed by NIOSH presentations that provide an overview of the FFFIPP and possible future directions. Representatives from seven stakeholder groups have accepted invitations to give 15-minute presentations on the usefulness of the FFFIPP and program products in their efforts to improve fire fighter safety and health, and their suggestions for enhancing the impact of the program and future directions. Stakeholders who will be giving presentations represent the United States Fire Administration, National Volunteer Fire Council, National Fire Protection Association, National Fallen Firefighters Foundation, National Wildfire Coordinating Group, International Association of Fire Chiefs, and International Association of Fire Fighters. An opportunity to make oral presentations will be provided to other interested parties, given available time on the agenda. The agenda currently includes time for fifteen 5minute presentations from other stakeholders. Requests to make such presentations at the meeting should be made by e-mail to the NIOSH Event Management Office (npptlevents@cdc.gov). All requests to present should include the name, address, telephone number, relevant business affiliations of the presenter, and a brief summary of the presentation. Oral presentations will be limited to 5 minutes. After reviewing the requests for presentation, NIOSH Event Management will notify each presenter of the approximate time that their presentation is scheduled to begin. If a participant is not present when their presentation is scheduled to begin, the remaining participants will be heard in order. The meeting will end with an interactive session providing the opportunity for clarification of stakeholder comments. Written comments without an oral presentation are also encouraged, and should be submitted to the NIOSH Docket Office as outlined in the next section. Docket: Written comments on the usefulness of the FFFIPP program and products for improving fire fighter safety and health and suggestions for enhancing the impact of the program and future directions should be mailed to: NIOSH Docket Office, Robert A. Taft Laboratories, M/S C34, 4676 Columbia Parkway, Cincinnati, Ohio 45226, Telephone 513–533–8303, Fax 513–533– 8285. Comments may also be submitted by e- PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 10539 mail to niocindocket@cdc.gov. E-mail attachments should be formatted in Microsoft Word. Comments should be submitted to NIOSH no later than April 22, 2006, and should reference the Docket Number in the subject heading. For Additional Information: Logistical Contact: NIOSH Event Management, 3604 Collins Ferry Road, Suite 100, Morgantown, West Virginia 26505–2353, Telephone 304– 599–5941 x138, Fax 304–225–2003, E-mail npptlevents@cdc.gov; Technical Contact: Dawn Castillo, Chief, Surveillance and Field Investigations Branch, Division of Safety Research, 304–285–6012. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 23, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–2837 Filed 2–28–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Proposed Collection; Comment Request; Educational Needs Assessment of International Drug Abuse Researchers SUMMARY: In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collection of information, the National Institute on Drug Abuse (NIDA), the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. Proposed Collection: Title: The NIDA International Program Research Training Modules for International Application Needs Assessment Survey. Type of Information Collection Request: NEW. Need and Use of Information Collection: This is a request for a one-time clearance to undertake an educational needs assessment survey of NIDA’s collaborating international drug abuse researchers. The purpose of this survey is to more precisely define the educational needs of the international drug abuse research community before proceeding with the development of formal distance learning programs. Reviews of distance education programs in the developing world often reveal that, ‘‘systematically organized learning E:\FR\FM\01MRN1.SGM 01MRN1 10540 Federal Register / Vol. 71, No. 40 / Wednesday, March 1, 2006 / Notices needs assessments are continually absent.’’ (USAID 2001: The Use and Effect of Distance Education in Healthcare: What Do We Know? Operations Research Issue Paper 2) This survey will address that issue. The survey is based on recommendations received from current international drug abuse researchers and NIDA grantees. It is designed to be brief (2 pages) and succinct, asking respondents to prioritize their educational needs. The questions have been previously tested with persons who speak English as a second language. Total time to complete the survey is less than five minutes. The survey will cover the following elements: (1) Respondent background, including availability of educational technologies, (2) Educational needs, including a ranking of 10 proposed topics in drug abuse education, and (3) Collaborative needs, including an estimate of the value of online tools for research collaboration. The survey will not collect name, address, or other identifying information. Frequency of Response: This project will be conducted once. Affected Public: International drug abuse researchers who are currently affiliated with or wish Estimated number of respondents Drug abuse researcher respondents to be affiliated with the U.S. drug abuse research community. Type of Respondents/Drug Abuse Researchers: physicians, scientists, mental health workers, and scientists-in-training. The reporting burden is as follows: Estimated Total Annual Number of Respondents: 250; Estimated Number of Responses per Respondent: 1; Average Burden Hours per Response: 0.09. Estimated Total Annual Burden Hours Requested: 22.5. There are no Capital Costs to report. There are no Operating or Maintenance Costs to report. The estimated annualized burden is summarized below. Estimated number of responses per respondent Average burden hours per response Estimated total burden hours Physicians ........................................................................................................ PhD Scientists ................................................................................................. Mental Health/Drug Abuse Professionals ........................................................ Scientists-in-Training ....................................................................................... 100 70 40 40 1 1 1 1 0.09 0.09 0.09 0.09 9.0 6.3 3.6 3.6 Annualized Totals ............................................................................................ 250 1 0.09 22.5 Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (2) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. To request more information on the proposed project or to obtain a copy of the information collection plans, contact Dale Weiss, Project Officer, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 5274, Bethesda, MD 20892, or call non-toll-free number 301– 402–6683; fax 301–443–9127; or by email to dweiss@nida.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. wwhite on PROD1PC61 with NOTICES FOR FURTHER INFORMATION CONTACT: VerDate Aug<31>2005 18:25 Feb 28, 2006 Jkt 208001 Dated: February 14, 2006. Laura Rosenthal, Associate Director for Management, National Institute on Drug Abuse. [FR Doc. E6–2824 Filed 2–28–06; 8:45 am] BILLING CODE 4167–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, SBIR Topic 216 Phase I/II ‘‘Fast Track Development of Inhibitory Reagents for the Study of Protein Function’’. Date: March 28, 2006. Time: 10:30 a.m. to 1 p.m. PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Executive Plaza North, 6130 Executive Boulevard, Conference Room J, Rockville, MD 20892, (Telephone Conference Call). Contact Person: Gerald G. Lovinger, PhD., Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8101, Bethesda, MD 20892–8329, (301) 496–7987, lovingeg@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: February 21, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–1879 Filed 2–28–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, March E:\FR\FM\01MRN1.SGM 01MRN1

Agencies

[Federal Register Volume 71, Number 40 (Wednesday, March 1, 2006)]
[Notices]
[Pages 10539-10540]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-2824]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed Collection; Comment Request; Educational Needs 
Assessment of International Drug Abuse Researchers

SUMMARY: In compliance with Section 3506(c)(2)(A) of the Paperwork 
Reduction Act of 1995 concerning opportunity for public comment on 
proposed collection of information, the National Institute on Drug 
Abuse (NIDA), the National Institutes of Health (NIH) will publish 
periodic summaries of proposed projects to be submitted to the Office 
of Management and Budget (OMB) for review and approval.
    Proposed Collection: Title: The NIDA International Program Research 
Training Modules for International Application Needs Assessment Survey. 
Type of Information Collection Request: NEW. Need and Use of 
Information Collection: This is a request for a one-time clearance to 
undertake an educational needs assessment survey of NIDA's 
collaborating international drug abuse researchers. The purpose of this 
survey is to more precisely define the educational needs of the 
international drug abuse research community before proceeding with the 
development of formal distance learning programs. Reviews of distance 
education programs in the developing world often reveal that, 
``systematically organized learning

[[Page 10540]]

needs assessments are continually absent.'' (USAID 2001: The Use and 
Effect of Distance Education in Healthcare: What Do We Know? Operations 
Research Issue Paper 2) This survey will address that issue.
    The survey is based on recommendations received from current 
international drug abuse researchers and NIDA grantees. It is designed 
to be brief (2 pages) and succinct, asking respondents to prioritize 
their educational needs. The questions have been previously tested with 
persons who speak English as a second language. Total time to complete 
the survey is less than five minutes. The survey will cover the 
following elements: (1) Respondent background, including availability 
of educational technologies, (2) Educational needs, including a ranking 
of 10 proposed topics in drug abuse education, and (3) Collaborative 
needs, including an estimate of the value of online tools for research 
collaboration. The survey will not collect name, address, or other 
identifying information. Frequency of Response: This project will be 
conducted once. Affected Public: International drug abuse researchers 
who are currently affiliated with or wish to be affiliated with the 
U.S. drug abuse research community. Type of Respondents/Drug Abuse 
Researchers: physicians, scientists, mental health workers, and 
scientists-in-training. The reporting burden is as follows: Estimated 
Total Annual Number of Respondents: 250; Estimated Number of Responses 
per Respondent: 1; Average Burden Hours per Response: 0.09. Estimated 
Total Annual Burden Hours Requested: 22.5. There are no Capital Costs 
to report. There are no Operating or Maintenance Costs to report. The 
estimated annualized burden is summarized below.

----------------------------------------------------------------------------------------------------------------
                                                                     Estimated
                                                     Estimated       number of        Average        Estimated
        Drug abuse researcher respondents            number of     responses per   burden hours    total burden
                                                    respondents     respondent     per response        hours
----------------------------------------------------------------------------------------------------------------
Physicians......................................             100               1            0.09             9.0
PhD Scientists..................................              70               1            0.09             6.3
Mental Health/Drug Abuse Professionals..........              40               1            0.09             3.6
Scientists-in-Training..........................              40               1            0.09             3.6
                                                 ---------------------------------------------------------------
Annualized Totals...............................             250               1            0.09            22.5
----------------------------------------------------------------------------------------------------------------

    Request for Comments: Written comments and/or suggestions from the 
public and affected agencies are invited on one or more of the 
following points: (1) Whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information shall have practical utility; (2) the 
accuracy of the agency's estimate of the burden of the proposed 
collection of information; (3) ways to enhance the quality, utility, 
and clarity of the information to be collected; and (4) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection 
plans, contact Dale Weiss, Project Officer, National Institute on Drug 
Abuse, 6001 Executive Boulevard, Room 5274, Bethesda, MD 20892, or call 
non-toll-free number 301-402-6683; fax 301-443-9127; or by e-mail to 
dweiss@nida.nih.gov.
    Comments Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 60 days 
of the date of this publication.

    Dated: February 14, 2006.
Laura Rosenthal,
Associate Director for Management, National Institute on Drug Abuse.
 [FR Doc. E6-2824 Filed 2-28-06; 8:45 am]
BILLING CODE 4167-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.